Objective:

To identify metabolic biomarkers that can differentiate pleural tuberculosis (PlTB) from pulmonary tuberculosis (PTB) and non-tuberculous pleural effusions, addressing the urgent need for improved diagnostic tools.

Approach:

Key Findings:

• Taurine, glycine, tryptophan, and kynurenine were identified as top metabolites for differentiating PlTB from PTB and non-TB pleural effusions, highlighting their potential clinical significance.

Interpretation:

The findings suggest that specific metabolic signatures may enhance the diagnostic accuracy for PlTB, potentially transforming current diagnostic practices.

Limitations:

• The study is a pilot investigation with a limited sample size, and potential biases or confounding factors should be considered.

Conclusion:

The study highlights the potential of metabolomic assays in improving the diagnosis of pleural tuberculosis and suggests next steps for further research and clinical application.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.